BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16112078)

  • 1. Some distinctions between flavin-containing and cytochrome P450 monooxygenases.
    Cashman JR
    Biochem Biophys Res Commun; 2005 Dec; 338(1):599-604. PubMed ID: 16112078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression.
    Hines RN; Cashman JR; Philpot RM; Williams DE; Ziegler DM
    Toxicol Appl Pharmacol; 1994 Mar; 125(1):1-6. PubMed ID: 8128486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human flavin-containing monooxygenases.
    Cashman JR; Zhang J
    Annu Rev Pharmacol Toxicol; 2006; 46():65-100. PubMed ID: 16402899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion.
    Leoni C; Buratti FM; Testai E
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):343-52. PubMed ID: 18845175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction.
    Katchamart S; Stresser DM; Dehal SS; Kupfer D; Williams DE
    Drug Metab Dispos; 2000 Aug; 28(8):930-6. PubMed ID: 10901703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development.
    Cashman JR
    Drug Discov Today; 2004 Jul; 9(13):574-81. PubMed ID: 15203093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug metabolism by flavin-containing monooxygenases of human and mouse.
    Phillips IR; Shephard EA
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):167-181. PubMed ID: 27678284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.
    Krueger SK; Williams DE
    Pharmacol Ther; 2005 Jun; 106(3):357-87. PubMed ID: 15922018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of flavin-containing monooxygenase in drug development.
    Cashman JR
    Expert Opin Drug Metab Toxicol; 2008 Dec; 4(12):1507-21. PubMed ID: 19040327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver microsome and flavin-containing monooxygenase catalyzed oxidation of organic selenium compounds.
    Chen GP; Ziegler DM
    Arch Biochem Biophys; 1994 Aug; 312(2):566-72. PubMed ID: 8037472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin in flavin-containing monooxygenase regulation. Flavin-containing monooxygenase and cytochrome P450 activities in experimental diabetes.
    Borbás T; Benko B; Dalmadi B; Szabó I; Tihanyi K
    Eur J Pharm Sci; 2006 May; 28(1-2):51-8. PubMed ID: 16488120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of ketoconazole and deacetylated ketoconazole by rat hepatic microsomes and flavin-containing monooxygenases.
    Rodriguez RJ; Acosta D
    Drug Metab Dispos; 1997 Jun; 25(6):772-7. PubMed ID: 9193882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism.
    Shephard EA; Phillips IR
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1083-94. PubMed ID: 20629583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
    Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
    Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.
    Halpert JR; Domanski TL; Adali O; Biagini CP; Cosme J; Dierks EA; Johnson EF; Jones JP; Ortiz de Montellano P; Philpot RM; Sibbesen O; Wyatt WK; Zheng Z
    Drug Metab Dispos; 1998 Dec; 26(12):1223-31. PubMed ID: 9860932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and modulation by drugs of sheep liver microsomal flavin monooxygenase activity.
    Can Demirdöğen B; Adali O
    Cell Biochem Funct; 2005; 23(4):245-51. PubMed ID: 15473006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the world of cytochrome P450 enzymes.
    Frye RF
    Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound lipophilicity as a descriptor to predict binding affinity (1/K(m)) in mammals.
    Pirovano A; Huijbregts MA; Ragas AM; Hendriks AJ
    Environ Sci Technol; 2012 May; 46(9):5168-74. PubMed ID: 22497447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human and plant flavin-containing monooxygenase N-oxygenation of amines: detoxication vs. bioactivation.
    Cashman JR
    Drug Metab Rev; 2002 Aug; 34(3):513-21. PubMed ID: 12214663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin.
    Parte P; Kupfer D
    Drug Metab Dispos; 2005 Oct; 33(10):1446-52. PubMed ID: 15987777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.